Bacterial drug resistance has become an increasingly major health problem.

WE, us humans, create bacterial drug resistance: humans are the actors in "natural selection" in this case.

One strategy to address bacterial drug resistance is the discovery and application of compounds that modify resistance to common antibacterials.

Additionally the activities of RecA are synonymous with antibiotic resistance development, and inhibitors of RecA may also serve to delay or prevent the appearance of bacterial drug resistance.